Key facts
CAS number:50-56-6,
Purity:>95%,
Form:SolidSee storage information,
Molecular weight:1007.2 Da,
Molecular formula:C43H66N12O12S2,
PubChem:439302,
Nature:Synthetic,
Solubility:Soluble in water,
Biochemical name:Oxytocin,
Canonical smiles:CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,
Isomeric smiles:CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,
InChi:InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1,
InChiKey:XNOPRXBHLZRZKH-DSZYJQQASA-N,
IUPAC Name:(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
Properties and Storage Information:
Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C, Storage information-Store under desiccating conditions, The product can be stored for up to 12 months
Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The AVPR1B AVPR2 (also known as V2R) and AVPR1A (also known as V1aR) are all part of the vasopressin receptor family. These receptors are G protein-coupled receptors (GPCRs) activated by the peptide hormone arginine vasopressin. These receptors mediate a variety of vasopressin's physiological effects in the body. The AVPR1B mostly appears in the anterior pituitary where it influences stress responses by modulating the release of adrenocorticotropic hormone (ACTH). AVPR2 is mostly expressed in the kidney playing a critical role in osmoregulation and AVPR1A is widely distributed impacting social behavior and circulation. The molecular mass of each receptor varies with AVPR2 around 40 kDa.
Biological function summary
These receptors transduce signals through the cyclic adenosine monophosphate (cAMP) pathway and phosphatidylinositol (PI) signaling. AVPR1B functions in the pituitary as part of the hypothalamic-pituitary-adrenal (HPA) axis. AVPR2 in the nephron facilitates the antidiuretic effect of vasopressin concentrating urine and maintaining water balance. Meanwhile AVPR1A influences cardiovascular functions and regulates blood pressure and volume. These receptors are independently functional not forming large protein complexes but they still coordinate important physiological processes in conjunction with vasopressin.
Pathways
These receptors connect primarily within the pituitary-adrenal axis and renal water reabsorption pathways. The AVPR1B receptor contributes significantly to the stress pathway through modulation of corticotrophin release in conjunction with corticotrophin-releasing hormone (CRH). AVPR2 is integral to the renal collecting duct's response in the antidiuretic pathway where it partners with aquaporin-2 to facilitate water reabsorption. Through these pathways vasopressin receptors ensure maintenance of fluid homeostasis and stress adaptation by interacting with other proteins such as CRH and aquaporin-2.
These receptors are linked to conditions like central diabetes insipidus and social anxiety disorders. AVPR2 mutations are well-documented in nephrogenic diabetes insipidus a condition where the kidneys fail to concentrate urine resulting in excessive waste of water. Dysfunctional AVPR1A and AVPR1B have implications in mental health disorders influencing conditions such as stress-related social anxiety due to their impact on HPA axis regulation. These connections emphasize the therapeutic potential targeting these receptors might have in treating such disorders by modulating related proteins like CRH and ACTH.
